181 related articles for article (PubMed ID: 36197115)
1. Direct capture, inhibition and crystal structure of HsaD (Rv3569c) from M. tuberculosis.
Barelier S; Avellan R; Gnawali GR; Fourquet P; Roig-Zamboni V; Poncin I; Point V; Bourne Y; Audebert S; Camoin L; Spilling CD; Canaan S; Cavalier JF; Sulzenbacher G
FEBS J; 2023 Mar; 290(6):1563-1582. PubMed ID: 36197115
[TBL] [Abstract][Full Text] [Related]
2. Cyclipostins and cyclophostin analogs inhibit the antigen 85C from
Viljoen A; Richard M; Nguyen PC; Fourquet P; Camoin L; Paudal RR; Gnawali GR; Spilling CD; Cavalier JF; Canaan S; Blaise M; Kremer L
J Biol Chem; 2018 Feb; 293(8):2755-2769. PubMed ID: 29301937
[TBL] [Abstract][Full Text] [Related]
3. Cyclipostins and Cyclophostin analogs as promising compounds in the fight against tuberculosis.
Nguyen PC; Delorme V; Bénarouche A; Martin BP; Paudel R; Gnawali GR; Madani A; Puppo R; Landry V; Kremer L; Brodin P; Spilling CD; Cavalier JF; Canaan S
Sci Rep; 2017 Sep; 7(1):11751. PubMed ID: 28924204
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the mycobacterial enzyme HsaD as a potential novel target for anti-tubercular agents using a fragment-based drug design approach.
Ryan A; Polycarpou E; Lack NA; Evangelopoulos D; Sieg C; Halman A; Bhakta S; Eleftheriadou O; McHugh TD; Keany S; Lowe ED; Ballet R; Abuhammad A; Jacobs WR; Ciulli A; Sim E
Br J Pharmacol; 2017 Jul; 174(14):2209-2224. PubMed ID: 28380256
[TBL] [Abstract][Full Text] [Related]
5. Lipolytic enzymes inhibitors: A new way for antibacterial drugs discovery.
Cavalier JF; Spilling CD; Durand T; Camoin L; Canaan S
Eur J Med Chem; 2021 Jan; 209():112908. PubMed ID: 33071055
[TBL] [Abstract][Full Text] [Related]
6. Biochemical and Structural Characterization of TesA, a Major Thioesterase Required for Outer-Envelope Lipid Biosynthesis in Mycobacterium tuberculosis.
Nguyen PC; Nguyen VS; Martin BP; Fourquet P; Camoin L; Spilling CD; Cavalier JF; Cambillau C; Canaan S
J Mol Biol; 2018 Dec; 430(24):5120-5136. PubMed ID: 30292819
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
[TBL] [Abstract][Full Text] [Related]
8. Sclerotiorin inhibits protein kinase G from Mycobacterium tuberculosis and impairs mycobacterial growth in macrophages.
Chen D; Ma S; He L; Yuan P; She Z; Lu Y
Tuberculosis (Edinb); 2017 Mar; 103():37-43. PubMed ID: 28237032
[TBL] [Abstract][Full Text] [Related]
9. Mechanism-based inhibition of HsaD: a C-C bond hydrolase essential for survival of Mycobacterium tuberculosis in macrophage.
Ryan A; Keany S; Eleftheriadou O; Ballet R; Cheng HY; Sim E
FEMS Microbiol Lett; 2014 Jan; 350(1):42-7. PubMed ID: 24164668
[TBL] [Abstract][Full Text] [Related]
10. Discovery of Mycobacterium tuberculosis α-1,4-glucan branching enzyme (GlgB) inhibitors by structure- and ligand-based virtual screening.
Dkhar HK; Gopalsamy A; Loharch S; Kaur A; Bhutani I; Saminathan K; Bhagyaraj E; Chandra V; Swaminathan K; Agrawal P; Parkesh R; Gupta P
J Biol Chem; 2015 Jan; 290(1):76-89. PubMed ID: 25384979
[TBL] [Abstract][Full Text] [Related]
11. Structure of HsaD, a steroid-degrading hydrolase, from Mycobacterium tuberculosis.
Lack N; Lowe ED; Liu J; Eltis LD; Noble ME; Sim E; Westwood IM
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2008 Jan; 64(Pt 1):2-7. PubMed ID: 18097091
[TBL] [Abstract][Full Text] [Related]
12. Oxadiazolone derivatives, new promising multi-target inhibitors against M. tuberculosis.
Nguyen PC; Delorme V; Bénarouche A; Guy A; Landry V; Audebert S; Pophillat M; Camoin L; Crauste C; Galano JM; Durand T; Brodin P; Canaan S; Cavalier JF
Bioorg Chem; 2018 Dec; 81():414-424. PubMed ID: 30212765
[TBL] [Abstract][Full Text] [Related]
13. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Tomioka H
Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
[TBL] [Abstract][Full Text] [Related]
14. Exploring the Potential Inhibition of Candidate Drug Molecules for Clinical Investigation Based on their Docking or Crystallographic Analyses against
Dey R; Nandi S; Samadder A; Saxena A; Saxena AK
Curr Top Med Chem; 2020; 20(29):2662-2680. PubMed ID: 32885754
[TBL] [Abstract][Full Text] [Related]
15. Cyclipostins and Cyclophostin Analogues as Multitarget Inhibitors That Impair Growth of
Madani A; Ridenour JN; Martin BP; Paudel RR; Abdul Basir A; Le Moigne V; Herrmann JL; Audebert S; Camoin L; Kremer L; Spilling CD; Canaan S; Cavalier JF
ACS Infect Dis; 2019 Sep; 5(9):1597-1608. PubMed ID: 31299146
[TBL] [Abstract][Full Text] [Related]
16. [Prospects for development of new antituberculous drugs].
Tomioka H
Kekkaku; 2002 Aug; 77(8):573-84. PubMed ID: 12235850
[TBL] [Abstract][Full Text] [Related]
17. Discovery of hydrazone containing thiadiazoles as Mycobacterium tuberculosis growth and enoyl acyl carrier protein reductase (InhA) inhibitors.
Doğan H; Doğan ŞD; Gündüz MG; Krishna VS; Lherbet C; Sriram D; Şahin O; Sarıpınar E
Eur J Med Chem; 2020 Feb; 188():112035. PubMed ID: 31951850
[TBL] [Abstract][Full Text] [Related]
18. NU-6027 Inhibits Growth of Mycobacterium tuberculosis by Targeting Protein Kinase D and Protein Kinase G.
Kidwai S; Bouzeyen R; Chakraborti S; Khare N; Das S; Priya Gosain T; Behura A; Meena CL; Dhiman R; Essafi M; Bajaj A; Saini DK; Srinivasan N; Mahajan D; Singh R
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31285226
[TBL] [Abstract][Full Text] [Related]
19. Docking- and pharmacophore-based virtual screening for the identification of novel Mycobacterium tuberculosis protein tyrosine phosphatase B (MptpB) inhibitor with a thiobarbiturate scaffold.
Zhang D; Lin Y; Chen X; Zhao W; Chen D; Gao M; Wang Q; Wang B; Huang H; Lu Y; Lu Y
Bioorg Chem; 2019 Apr; 85():229-239. PubMed ID: 30641319
[TBL] [Abstract][Full Text] [Related]
20. Study of mechanism of interaction of truncated isoniazid-nicotinamide adenine dinucleotide adduct against multiple enzymes of Mycobacterium tuberculosis by a computational approach.
Jena L; Deshmukh S; Waghmare P; Kumar S; Harinath BC
Int J Mycobacteriol; 2015 Dec; 4(4):276-83. PubMed ID: 26964808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
